NCT01511198 Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent Status COMPLETED Phase PHASE2
NCT01511185 Effect of Liraglutide on the Beta-cell Responsiveness in Subjects With Type 2 Diabetes Compared to a Healthy Control Group Status COMPLETED Phase PHASE1
NCT01511172 Effect of Liraglutide as add-on to Metformin Compared to Either Liraglutide or Metformin Alone, or to a Combination of Metformin and a SU (Sulphonylurea) Agent in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01511159 Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01509755 Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01509742 Effect of Liraglutide on Glucagon Secretion in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01508949 Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01508923 Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01508897 Comparison of Two Liraglutide Formulations in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01508858 Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women Status COMPLETED Phase PHASE1
NCT01508806 Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function Status COMPLETED Phase PHASE1
NCT01507454 Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency Status COMPLETED Phase N/A
NCT01507389 Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function Status COMPLETED Phase PHASE1
NCT01507337 Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01507311 Effect of Liraglutide on Pulsatile Insulin Secretion in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01507285 Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01507272 Safety and Tolerability of Liraglutide in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01505673 Adding Liraglutide to High Dose Insulin: Breaking the Cycle Status COMPLETED Phase PHASE4